Arm 2Arm 3Arm 1nivolumabdegarelixprostate cancerNCT04989946pTVG-AR
…ed reduced CD4+cells with a regulatory phenotype in patients in Arm 2.Conclusion In this first stage of a pilot study that awaits con…
2articles mentioning institutions
5institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Arm 2 ×
Arm 2
This institution is selected. Its supporting articles are shown below.
Articles mentioning Arm 2
2 articles · page 1 of 1Arm 2tuvusertibceralasertibdurvalumabavelumabAZD6738
…mg QD on days 1-14 of each 21-day cycle (figure 2). Subjects in Arm 2 also receive avelumab 1600 mg IV on day 1 of each cycle. Imagin…